The thesis
PanicFade v4 makes a specific, testable bet: negative headline shocks are overreacted to, and prices revert toward fundamentals once the emotion drains out. Mechanically, it buys names hit by a sentiment reading below -0.4 that are already oversold — RSI14 under 35 and trading below their 20-day average — and sizes into the panic rather than flinching from it. Exits are equally disciplined: it takes profit on reversion (RSI14 back above 50 or a reclaim of the SMA20) and hard-stops on fresh lows under continued negativity, treating that as evidence the selloff was a genuine fundamental break, not a mood swing.
The design leans on recent literature — an arXiv q-fin paper on sentiment feedback asymmetries (2509.11970), corroborated by stock-level investor-sentiment work in JRFM. That grounding matters: this is a strategy with a stated why, not a curve-fit pattern.
Validation: encouraging, honestly framed
The walk-forward results are the strongest part of the story. Across four out-of-sample folds spanning late 2021 to August 2026, all four were positive — a 21.7% out-of-sample return with a 2.44 Sharpe in the most recent fold, and a Deflated Sharpe Ratio of 0.56 against 27 trials. A PSR of 0.985 suggests the edge is unlikely to be pure luck.
But read the folds in order. Fold 1 returned just 1.6% at a 0.19 Sharpe; fold 2 managed 3.88%. The eye-catching numbers are concentrated in folds 3 and 4. That improvement could reflect a genuinely favourable recent regime for mean-reversion rather than a stable, all-weather edge — the honest reading is promising in calm-to-recovering markets, unproven in the next crash.
Backtest economics
The full backtest shows a 37.93% total return over 1,233 days, or a 6.79% CAGR, with a 9.3% max drawdown and a 62.88% win rate across 530 trades. That's a respectable risk-adjusted profile (0.96 Sharpe), but two things temper it. First, the CAGR is modest — this is a singles-hitter, not a compounder. Second, turnover is enormous at 5,807%, meaning fees and slippage are a real, ongoing drag; the fixed-fee model here charged $530 across those trades.
Live activity: mostly waiting
The live account tells its own story: patience, bordering on inactivity. On a $10,000 base, total equity sits around $10,045 with roughly $8,959 in cash — meaning the strategy is barely deployed. Recent scheduled runs report "0 executed" day after day, with a single exception: a 10-share WMT buy at $103.115 on 28 August.
That's by design — PanicFade only acts when panic and oversold conditions coincide, which is rare in a grinding-higher tape. The upside is discipline. The risk is opportunity cost: capital idle for weeks earns nothing, and the strategy's real test only arrives when the market actually panics.
Verdict
A well-reasoned, cleanly validated contrarian strategy that has yet to be stress-tested live. Watch two things: whether it deploys meaningfully when volatility returns, and whether that recent-fold outperformance survives a genuine drawdown.